Brief: Avidity Biosciences Confirms Accelerated Approval Path for Del-Zota with BLA Planned For Year End 2025
08/01/2025 14:39
Jan 8 (Reuters) - Avidity Biosciences Inc RNA.O :
* AVIDITY BIOSCIENCES: ACCELERATED APPROVAL PATH CONFIRMED
FOR
DEL-ZOTA; BLA SUBMISSION PLANNED FOR YEAR END 2025
Source text: urn:newsml:reuters.com:*:nPn2BTczXa
Further company coverage: RNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avidity Biosciences
See all newsFactbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
Brief: Avidity Biosciences Says Record Date Set For February 12, 2026 For Spin-Off